| Assess the Safety and Tolerability of SNS851 in Healthy Participants (NCT07417124) | Oneness Biotech Co., Ltd. | 2026-04-01 |
| Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers (NCT06531512) | Oneness Biotech Co., Ltd. | 2024-08-16 |
| Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis (NCT06397911) | Oneness Biotech Co., Ltd. | 2024-08-08 |
| A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients (NCT05941793) | Oneness Biotech Co., Ltd. | 2023-09-11 |
| A Study to Evaluate the Safety and Bridging PK Profile of FB825 for Single Subcutaneous Administration in Healthy Adults (NCT05952986) | Oneness Biotech Co., Ltd. | 2023-05-03 |
| A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants (NCT05677893) | Oneness Biotech Co., Ltd. | 2022-11-07 |
| Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B) (NCT05438251) | Oneness Biotech Co., Ltd. | 2022-08-04 |
| Retrospective Record-review Study in Patients Who Had Diabetic Foot Ulcer (NCT05135130) | Oneness Biotech Co., Ltd. | 2021-10-04 |
| Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma (NCT05018299) | Oneness Biotech Co., Ltd. | 2021-09-30 |
| Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma (NCT05008965) | Oneness Biotech Co., Ltd. | 2021-07-27 |
| Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers (NCT04962139) | Oneness Biotech Co., Ltd. | 2021-07-27 |
| A Research Study to Evaluate the Safety and Potential Efficacy of ON101 Cream for the Treatment of Venous Leg Ulcers. (NCT05322525) | Oneness Biotech Co., Ltd. | 2021-06-23 |
| A Randomized,Double-blind,Placebo-controlled Clinical Study to Explore the Mechanism of Action of ON101 Cream in Patients With DFUs. (NCT04945161) | Oneness Biotech Co., Ltd. | 2021-02-23 |
| Evaluate Safety, Tolerability, PK, Preliminary Clinical Activity of OB318 in Patients With Advanced Solid Malignancies (NCT02347228) | Oneness Biotech Co., Ltd. | 2020-08-28 |
| Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis (NCT04413942) | Oneness Biotech Co., Ltd. | 2020-03-10 |
| Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis (NCT05059509) | Oneness Biotech Co., Ltd. | 2020-02-06 |